Uni- and multivariate analyses of prognostic factors for PFS and OS in 80 patients with ovarian cancer, FIGO stages I–IV
The following parameters were included in the analyses: tumor stage (FIGO Stages I and II versus Stages III and IV), residual tumor (presence or absence), age (≤56 years versus >56 years), uPA (≤5.5 versus >5.5 ng/mg protein), PAI-1 (≤18.8 versus >18.8 ng/mg protein), and grading (G1, G2, G3, or G4). . | . | . | . | . | ||||
---|---|---|---|---|---|---|---|---|
Ps for PFS | Ps for OS | |||||||
Univariate | Multivariate | Univariate | Multivariate | |||||
FIGO stage | 0.005 | 0.95 | 0.016 | 0.88 | ||||
Residual tumor volume | <0.0001 | 0.0005 | 0.0003 | 0.025 | ||||
uPA | 0.003 | 0.037 | 0.0002 | 0.006 | ||||
PAI-1 | 0.039 | 0.31 | 0.007 | 0.582 | ||||
Age | 0.059 | 0.0008 | 0.15 | 0.018 | ||||
Grading | 0.0002 | 0.962 | 0.004 | 0.882 |
The following parameters were included in the analyses: tumor stage (FIGO Stages I and II versus Stages III and IV), residual tumor (presence or absence), age (≤56 years versus >56 years), uPA (≤5.5 versus >5.5 ng/mg protein), PAI-1 (≤18.8 versus >18.8 ng/mg protein), and grading (G1, G2, G3, or G4). . | . | . | . | . | ||||
---|---|---|---|---|---|---|---|---|
Ps for PFS | Ps for OS | |||||||
Univariate | Multivariate | Univariate | Multivariate | |||||
FIGO stage | 0.005 | 0.95 | 0.016 | 0.88 | ||||
Residual tumor volume | <0.0001 | 0.0005 | 0.0003 | 0.025 | ||||
uPA | 0.003 | 0.037 | 0.0002 | 0.006 | ||||
PAI-1 | 0.039 | 0.31 | 0.007 | 0.582 | ||||
Age | 0.059 | 0.0008 | 0.15 | 0.018 | ||||
Grading | 0.0002 | 0.962 | 0.004 | 0.882 |